Our clinical trials network is running a trial on ceftriaxone, and a few of the centres are running a second trial. Some of our clinicians work as part of American groups also, so there's an advantage there. We could carry out more trials, because there are things on the launch pad waiting to be tried. For example, I was at the American Academy of Neurology conference in April, and in the session they were talking about the progression of clinical trials from phase one, which is just safety, through phase three, which is the full-blown proper clinical trial. And there are a number of candidates sort of waiting their turn.
On June 8th, 2010. See this statement in context.